WELLINGTON MANAGEMENT GROUP LLP
Position in ADPT — Adaptive Biotechnologies Corp
CIK 902219
Boston, MA
Position in ADPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,477,842
+53.2% QoQ
Ownership
0.926%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 71%
None 29%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $9,825,573,966 across 22 Diagnostics & Research names. ADPT ranks #22 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
16,316,834 | $3,108,030,536 | |
| 2 | NTRA |
Natera, Inc.
|
4,040,738 | $1,096,858,326 | |
| 3 | A |
Agilent Technologies, Inc.
|
7,454,686 | $990,205,937 | |
| 4 | ICLR |
Icon PLC
|
5,320,054 | $924,146,575 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
459,064 | $586,458,847 | |
| 6 | WAT |
Waters Corp /De/
|
1,373,150 | $514,986,171 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
979,181 | $490,922,182 | |
| 8 | QGEN |
Qiagen N.V.
|
12,406,763 | $485,104,431 |
All Filings in ADPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 5,911,366 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | — | 3,857,422 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | — | 2,165,327 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | — | 501,084 | Shares | Defined | 2025-11-14 | |
| 2020-12-31 | — | 56,311 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | — | 182,814 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | — | 500,624 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | — | 3,243,245 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||